[18F]-SP203

N/A

Report date: 2025/11/24 17:27:14
NME

Base Information

Drug Name[18F]-SP203
Drug Alias Name[18F]-SP-203
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[5] 
Mechanisms of ActionMetabotropic glutamate receptor 5 modulators
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Mental HealthNational Institute Of Mental Health (Nimh)
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksN/A